SJOGREN'S SYNDROME (SS)
Clinical trials for SJOGREN'S SYNDROME (SS) explained in plain language.
Never miss a new study
Get alerted when new SJOGREN'S SYNDROME (SS) trials appear
Sign up with your email to follow new studies for SJOGREN'S SYNDROME (SS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy tested for patients Who've tried everything else
Disease control Recruiting nowThis is an early safety study testing a single infusion of a new cell therapy called YTS109. It aims to see if the treatment is safe and shows any signs of helping adults with severe autoimmune diseases that have not responded to standard treatments. The study will enroll about 1…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
One-Shot gene therapy trial aims to reset immune system in devastating diseases
Disease control Recruiting nowThis is an early-stage study testing a new, one-time treatment called TI-0032-III injection for people with severe autoimmune diseases that have not improved with standard medications. The treatment uses a single injection of genetic material to reprogram the patient's own immune…
Matched conditions: SJOGREN'S SYNDROME (SS)
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC